BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25634571)

  • 1. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
    Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
    Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 expression in sweat gland tumors.
    Biernat W; Woźniak L
    Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological Expression of p16INK4a is Commonly Present Both in Benign and Malignant Sweat Gland Neoplasias.
    Tsujita J; Kaku Y; Ichiki T; Eto A; Maemura H; Otsuka A; Nakaie R; Kitagawa N; Morioka Y; Matsuda T; Yoshida M; Furue M
    Fukuoka Igaku Zasshi; 2015 Dec; 106(12):323-9. PubMed ID: 27159948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
    Ansai S
    Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers.
    Sellheyer K
    J Cutan Pathol; 2015 Feb; 42(2):90-101. PubMed ID: 25354097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.
    Dias-Santagata D; Lam Q; Bergethon K; Baker GM; Iafrate AJ; Rakheja D; Hoang MP
    Mod Pathol; 2011 Jul; 24(7):974-82. PubMed ID: 21423156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic significance of the myoepithelial cells in the benign and malignant sweat gland tumors.
    Biemat W; Kordek R; Woźniak L
    Pol J Pathol; 1996; 47(1):7-11. PubMed ID: 8705271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 distribution in sweat gland tumors suggests it has different functional roles in the various cell types.
    Fernández-Figueras MT; Puig L; Ariza A; Calatrava A; Fuente MJ; Ferrándiz C
    Am J Dermatopathol; 1996 Oct; 18(5):483-9. PubMed ID: 8902095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYB, CD117 and SOX-10 expression in cutaneous adnexal tumors.
    Evangelista MT; North JP
    J Cutan Pathol; 2017 May; 44(5):444-450. PubMed ID: 28098399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors.
    Eckert F; de Viragh PA; Schmid U
    J Cutan Pathol; 1994 Apr; 21(2):140-50. PubMed ID: 7518849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvar adnexal lesions: a 32-year, single-institution review from Massachusetts General Hospital.
    Baker GM; Selim MA; Hoang MP
    Arch Pathol Lab Med; 2013 Sep; 137(9):1237-46. PubMed ID: 23991738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.
    Vila L; Liu H; Al-Quran SZ; Coco DP; Dong HJ; Liu C
    Mod Pathol; 2009 Oct; 22(10):1296-302. PubMed ID: 19617878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA image cytometry in malignant and benign sweat gland tumours.
    Vogelbruch M; Böcking A; Rütten A; Kapp A; Kiehl P
    Br J Dermatol; 2000 Apr; 142(4):688-93. PubMed ID: 10792218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
    Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
    Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary hidradenoma of the eyelid margin: clinical and immunohistochemical observations further supporting an apocrine rather than an eccrine origin.
    Jakobiec FA; Rai R; Lefebvre DR
    Surv Ophthalmol; 2014; 59(5):540-7. PubMed ID: 24661803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity for estrogen receptor protein in sweat gland tumors.
    Swanson PE; Mazoujian G; Mills SE; Campbell RJ; Wick MR
    Am J Surg Pathol; 1991 Sep; 15(9):835-41. PubMed ID: 1951842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.